Skip to main content
Richard Van Etten, MD, Hematology, Orange, CA

RichardA.Van EttenMDPhD

Hematology • Orange, CA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Professor of Medicine, University of California Irvine; Director, Chao Family Comprehensive Cancer Center

Join to view full profile

Dr. Van Etten is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Van Etten's full profile

Already have an account?

  • Office

    101 The City Dr S
    Orange, CA 92868
    Phone+1 714-456-5153
    Fax+1 855-211-3729

Summary

  • Dr. Richard Van Etten is a hematologist in Orange, CA and is affiliated with UC Irvine Medical Center, where he is the Director of UCI's Chao Family Comprehensive Cancer Center, a comprehensive cancer center designated by the National Cancer Institute. He received his medical degree from Stanford University School of Medicine and has been in practice 33 years. He specializes in hematologic oncology and myeloproliferative disorders and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1984 - 1987
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1984
  • M.I.T.
    M.I.T.BS, Biology and Mathematics, 1974 - 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2025
  • MA State Medical License
    MA State Medical License 1986 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Press Mentions

  • Helio Genomics’ HelioLiver Dx Test Meets Coprimary and Secondary Study Endpoints in the CLiMB Trial, Presented at the EASL Congress 2024
    Helio Genomics’ HelioLiver Dx Test Meets Coprimary and Secondary Study Endpoints in the CLiMB Trial, Presented at the EASL Congress 2024June 10th, 2024

Dr. Richard Van Etten, Dr. Richard Van Etten, MD, Dr. R Van Etten, Dr. Richard A. Van Etten